Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Directly Acting Antivirals”

182 trials

Showing 20 of 182 results

Not applicableUnknownNCT03268317
What this trial is testing

Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs

Who this might be right for
Hepatitis C
Assiut University 100
Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Early research (Phase 1)Study completedNCT02185794
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 101
Post-approval studies (Phase 4)Ended earlyNCT03625687
What this trial is testing

Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant

Who this might be right for
Respiratory FailureHepatitis C
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Not applicableUnknownNCT03897608
What this trial is testing

Quality of Life in Patients With HCV Related Liver Cirrhosis Before and After Direct Acting Antiviral Drugs

Who this might be right for
HCV Related Liver Cirrhosis Direct Acting Antiviral Drugs
Assiut University 50
Post-approval studies (Phase 4)UnknownNCT04169464
What this trial is testing

The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy

Who this might be right for
Egyptian Patients, HCV Treatment, Kidney Function
MTI University 200
Not applicableUnknownNCT03820102
What this trial is testing

Impact of Metabolic Changes and Vitamin D Status on Virological Response in Patients With HCV Infection Treated by DAAs

Who this might be right for
HCV
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Not applicableUnknownNCT04039698
What this trial is testing

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Who this might be right for
Chronic Hepatitis C
Hospital de Clinicas de Porto Alegre 144
Not applicableUnknownNCT02904603
What this trial is testing

Immune Monitoring of Hepatitis C Under DAA Therapy

Who this might be right for
Hepatitis C
University of Regensburg 100
Post-approval studies (Phase 4)Ended earlyNCT03208244
What this trial is testing

DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant

Who this might be right for
End Stage Heart DiseaseHepatitis C
Massachusetts General Hospital 40
Not applicableStudy completedNCT02824640
What this trial is testing

Patient-Centered Models of HCV Care for People Who Inject Drugs

Who this might be right for
Hepatitis CMedication Adherence
Prisma Health-Upstate 755
Not applicableApproved For MarketingNCT01779518
What this trial is testing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences
Not applicableStudy completedNCT04330508
What this trial is testing

Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial

Who this might be right for
Depression in Chronic Hepatitis C
Post Graduate Institute of Medical Education and Research, Chandigarh 385
Not applicableUnknownNCT05372874
What this trial is testing

Treatment of Hepatitis c by Using Direct-acting Antiviral

Who this might be right for
Hepatitis C
Tanta University 50
Not applicableStudy completedNCT07702396
What this trial is testing

Efficacy of 12 Weeks Versus 24 Weeks Treatment of Directly Acting Antiviral Therapy in Patients With Hepatitis C Related Chronic Liver Disease

Who this might be right for
Heptatitis C
Indus Hospital and Health Network 192
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Not applicableStudy completedNCT03346941
What this trial is testing

Side Effects After Direct-acting Antiviral Treatment

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 95
Post-approval studies (Phase 4)Study completedNCT02064049
What this trial is testing

Surveillance and Treatment of Prisoners With Hepatitis C

Who this might be right for
Hepatitis C
Kirby Institute 3,692
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation